Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SCHLX vs. LOGSX: which is better?

Bottom line

SCHLX vs LOGSX: the short answer

SCHLX (DWS Health and Wellness Fund) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared.

But SCHLX is far broader, holding 65 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.

LOGSX is cheaper at 1.04% vs 1.06% — a difference of $2.00 a year per $10,000 invested.

Updated Nov 19, 2026

SCHLX vs LOGSX side by side

SCHLXLOGSX
TypeMutual fundMutual fund
Fund familyDWS (Xtrackers)Oak Associates
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.06%1.04%
Annual cost per $10k$106$104
10-yr cost on $10k (prospectus)$1,294$1,271
Max front load0%—
12b-1 fee0%—
1-yr return—+19.6%
5-yr return (annualized)—+8.1%
10-yr return (annualized)—+7.3%
Best quarter—+13.4%
Worst quarter—−13.1%
Net assets (fund)$231.8M$56.1M
Number of holdings6528
Portfolio turnover2%24%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

14 of SCHLX's top 25 holdings also appear in LOGSX's top 25.

Shared top holdings
HoldingSCHLXLOGSX
Eli Lilly & Co13.85%1.99%
Johnson & Johnson6.19%3.77%
Merck & Co Inc4.85%3.16%
Novartis AG2.90%4.67%
Amgen Inc2.88%4.86%
Gilead Sciences Inc2.78%3.50%
Intuitive Surgical Inc2.69%2.99%
Vertex Pharmaceuticals Inc2.45%3.26%
McKesson Corp2.05%4.53%
Novo Nordisk A/S1.73%2.51%
Bristol-Myers Squibb Co1.50%4.02%
Regeneron Pharmaceuticals Inc1.43%4.43%
Cardinal Health Inc1.34%5.86%
Cencora Inc1.26%4.46%

Source: SEC Form N-PORT

SCHLX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

FAQ

What is the difference between SCHLX and LOGSX?
SCHLX (DWS Health and Wellness Fund) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared. But SCHLX is far broader, holding 65 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
Which is cheaper, SCHLX or LOGSX?
LOGSX has the lower expense ratio (1.04%).
Should I own both SCHLX and LOGSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.